Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 2, 1998, Pages 190-196

  Halsas, M ^a   Ervasti, P ^a   Veski, P ^b   Jurjenson H ^c   Marvola, M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TARTU   (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Bioavailability; Coating; Compression; Hydrophilic polymers; Release; Tablets; Time controlled

Indexed keywords

ALGINIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; POLYMER;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; MODEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TABLET PROPERTY; VISCOSITY;

EID: 0031665720     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189338     Document Type: Conference Paper

References (10)

1. Marvola M., Sirkiä T. (1995): Controlled release pharmaceutical preparations, Finnish patent 93924.
2. Sirkiä T., Antila J., Marvola M., Kauppi M., Happonen I. (1993): Use of hydrophilic polymers to control drug release from press-coated oxybutynin hydrochloride tablets. S.T.P. Pharma Sci., 3, 453-458.
3. Sirkiä T., Salonen H., Veski P., Jürjenson H. and Marvola M. (1994): Biopharmaceutical evaluation of new prolonged -release press-coated ibuprofen tablets containing sodium alginate to adjust drug release. Int. J. Pharm., 107, 179-187.
4. Ritschel W.A. (1992): Handbook of basic pharmacokinetics 4th edn, Drug intelligence publifications, Hamilton press, Illinois, p. 541.
5. Wilson C.G., Washington N. (1988): Assessment of disintegration and dissolution of dosage forms in vivo using gamma scintigraphy. Drug. Dev. Ind. Pharm., 14, 211-281.
6. Labrecque G., Bureau J-P., Reinberg A.E. (1995): Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs. Pharm. Ther., 66, 285-300.
7. Avgerinos A., Hutt, A.J. (1986): High-performance liquid chromatographic determinations of ibuprofen in human plasma and urine by direct injection. J. Chromatogr., 380, 468-471.
8. Shah V.P., Midha K.K., Dighe S., et al, (1992): Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. J. Pharm. Sci., 81, 309-312.
9. Wilson C.G., Washington N., Greaves J.L., et al J.F. (1989): Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake. Int. J. Pharm., 50, 155-161.
10. Alderman D.S., (1984): Review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int.J.Pharm. Tech. & Prod. Mfr., 5, 1-9.